Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
Megna M, Potestio L, Fabbrocini G, Cinelli E. Megna M, et al. Among authors: potestio l. Dermatol Ther. 2021 Sep;34(5):e15030. doi: 10.1111/dth.15030. Epub 2021 Jun 22. Dermatol Ther. 2021. PMID: 34137492 Free PMC article. No abstract available.
Scabies outbreak during COVID-19: an Italian experience.
De Lucia M, Potestio L, Costanzo L, Fabbrocini G, Gallo L. De Lucia M, et al. Among authors: potestio l. Int J Dermatol. 2021 Oct;60(10):1307-1308. doi: 10.1111/ijd.15809. Epub 2021 Aug 5. Int J Dermatol. 2021. PMID: 34351621 Free PMC article. No abstract available.
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Villani A, Ocampo-Garza SS, Potestio L, Fabbrocini G, Ocampo-Candiani J, Ocampo-Garza J, Scalvenzi M. Villani A, et al. Among authors: potestio l. Expert Opin Drug Saf. 2022 Jan;21(1):21-29. doi: 10.1080/14740338.2022.1993819. Epub 2021 Nov 1. Expert Opin Drug Saf. 2022. PMID: 34644510 Review.
Letter to the editor regarding article "Yalici-Armagan B, Tabak GH, Dogan-Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID-19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1-5".
Potestio L, Camela E, Fabbrocini G, Megna M. Potestio L, et al. J Cosmet Dermatol. 2021 Dec;20(12):4073-4075. doi: 10.1111/jocd.14550. Epub 2021 Oct 28. J Cosmet Dermatol. 2021. PMID: 34708906 Free PMC article. No abstract available.
154 results